← Back to Clinical Trials
Recruiting EARLY_Phase 1 NCT07093060
The Effect of Oral Oxytocin and Atosiban on Social Attention
◆ AI Clinical Summary
Plain-language summary for patients
Trial Parameters
Condition Healhty
Sponsor University of Electronic Science and Technology of China
Study Type INTERVENTIONAL
Phase EARLY_Phase 1
Enrollment 250
Sex MALE
Min Age 18 Years
Max Age 35 Years
Start Date 2025-06-09
Completion 2025-11-30
Interventions
Oxytocin lower dose (24IU)Oxytocin higher dose (48IU)Atosiban
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
The main aim of the present study is to investigate whether orally (lingual spray) administered oxytocin influences human social attention and behaviors via oxytocin receptors and whether its effects are dose- and task-dependent.
Eligibility Criteria
Inclusion Criteria: * Healthy male subjects without past or current psychiatric or neurological disorders Exclusion Criteria: * History of or current neurological/psychiatric disorders; * Use of psychotropic medications (including nicotine) * Visual impairments
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology